Literature DB >> 9876052

Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review.

P Periti1, T Mazzei.   

Abstract

This article reviews the new criteria for selecting the proper antimicrobial agent and dosage regimen for standard treatment of severe sepsis, with the intention of preventing septic shock. After introducing new concepts on the pathogenesis of sepsis and septic shock, the authors analyze the parameters of betalactam antibacterial activity, the antibiotic-induced release of bacterial endotoxin and the interrelationships between pharmacokinetics and pharmacodynamics of antibiotics in the search for an optimum dosage regimen of antimicrobial mono- or polytherapy for severely ill septic patients admitted to the intensive care unit.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9876052     DOI: 10.1179/joc.1998.10.6.427

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  14 in total

1.  Hypothesis: is a failure to prevent bacteriolysis and the synergy among microbial and host-derived pro-inflammatory agonists the main contributory factors to the pathogenesis of post-infectious sequelae?

Authors:  I Ginsburg
Journal:  Inflammation       Date:  2001-02       Impact factor: 4.092

2.  Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors.

Authors:  Lena Heinbockel; Susana Sánchez-Gómez; Guillermo Martinez de Tejada; Sabine Dömming; Julius Brandenburg; Yani Kaconis; Mathias Hornef; Aline Dupont; Sebastian Marwitz; Torsten Goldmann; Martin Ernst; Thomas Gutsmann; Tobias Schürholz; Klaus Brandenburg
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

3.  Differential tumor necrosis factor alpha expression and release from peritoneal mouse macrophages in vitro in response to proliferating gram-positive versus gram-negative bacteria.

Authors:  W Cui; D C Morrison; R Silverstein
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

4.  Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis.

Authors:  R Silverstein; J G Wood; Q Xue; M Norimatsu; D L Horn; D C Morrison
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

5.  n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa.

Authors:  Evangelos J Giamarellos-Bourboulis; Maria Mouktaroudi; Theodoros Adamis; Vassilios Koussoulas; Fotini Baziaka; Despina Perrea; Panayotis E Karayannacos; Helen Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

6.  Biophysical characterization of endotoxin inactivation by NK-2, an antimicrobial peptide derived from mammalian NK-lysin.

Authors:  Jörg Andrä; Michel H J Koch; Rainer Bartels; Klaus Brandenburg
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 7.  A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria.

Authors:  Francis C Neuhaus; James Baddiley
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

8.  Integrative metabolomics and transcriptomics identifies itaconate as an adjunct therapy to treat ocular bacterial infection.

Authors:  Sukhvinder Singh; Pawan Kumar Singh; Alokkumar Jha; Poonam Naik; Joveeta Joseph; Shailendra Giri; Ashok Kumar
Journal:  Cell Rep Med       Date:  2021-05-18

9.  Multi-drug strategies are necessary to inhibit the synergistic mechanism causing tissue damage and organ failure in post infectious sequelae.

Authors:  I Ginsburg
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 5.093

10.  Heparin-based blood purification attenuates organ injury in baboons with Streptococcus pneumoniae pneumonia.

Authors:  Lingye Chen; Bryan D Kraft; Victor L Roggli; Zachary R Healy; Christopher W Woods; Ephraim L Tsalik; Geoffrey S Ginsburg; David M Murdoch; Hagir B Suliman; Claude A Piantadosi; Karen E Welty-Wolf
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-06-09       Impact factor: 6.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.